Notoginsenoside R1, An Active Compound from Panax notoginseng, Inhibits Hepatic Stellate Cell Activation and Liver Fibrosis via MAPK Signaling Pathway

肝星状细胞 三七 四氯化碳 肝纤维化 化学 纤维化 医学 肝损伤 库普弗电池 病理 内分泌学 药理学 内科学 有机化学 替代医学
作者
Xu Gong,Linlin Shan,Sisi Cao,Kaitao Li,Yanli Wu,Qing Zhang
出处
期刊:The American Journal of Chinese Medicine [World Scientific]
卷期号:50 (02): 511-523 被引量:12
标识
DOI:10.1142/s0192415x22500197
摘要

Activation of the hepatic stellate cell is implicated in pathological vascularization during development of liver fibrosis. MAPK signaling is involved in the activation of hepatic stellate cell. Oxidative stress and inflammation are also involved in the pathogenesis of liver fibrosis. Notoginsenoside R1 is an effective saponin isolated from the roots of Panax notoginseng (Burk) F. H. Chen and exerts anti-oxidant, anti-inflammatory and anti-fibrotic roles in various diseases. However, the role of Notoginsenoside R1 in liver fibrosis has not been investigated yet. First, a rat model with liver fibrosis was established through oral gavage administration with carbon tetrachloride. Data from hematoxylin and eosin (H&E) and Masson's trichrome stainings showed that carbon tetrachloride induced severe hepatic damages, including inflammatory cell infiltration, lipid droplets deposition in hepatocytes and liver centrilobular necrosis. Meanwhile, the rats were also intraperitoneal injected with different concentrations of Notoginsenoside R1. Results demonstrated that Notoginsenoside R1 treatment suppressed the pathological changes in the livers with enhanced levels of ALB and TP, and reduced levels of ALP, AST and ALT. Second, Notoginsenoside R1 also significantly attenuated carbon tetrachloride-induced decrease in PPAR-[Formula: see text] and increase in Coll-a1, [Formula: see text]-SMA and TIMP1 in liver tissues ([Formula: see text][Formula: see text] 0.001). Third, the decrease in GSH, SOD and GST and increase in MDA, IL-1[Formula: see text], IL-6 and TNF-[Formula: see text] induced by carbon tetrachloride were markedly restored by Notoginsenoside R1 ([Formula: see text][Formula: see text] 0.001). Lastly, Notoginsenoside R1 counteracted with the promotive effects of carbon tetrachloride on levels of proteins involved in MAPK signaling, including phosphorylated p65 (p-p65), p-ERK, p-JNK and p-p38. In conclusion, Notoginsenoside R1 suppressed the activation of hepatic stellate cells and exerted anti- oxidant and anti-inflammatory to attenuate carbon tetrachloride-induced liver fibrosis through inactivation of NF-[Formula: see text]B and MAPK signaling.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
思源应助虚心天思采纳,获得10
刚刚
1秒前
2秒前
2秒前
罗维发布了新的文献求助30
3秒前
慢慢地漫漫完成签到,获得积分10
5秒前
秋雪瑶应助雨洋采纳,获得10
5秒前
oldblack完成签到,获得积分10
6秒前
任性的水风给任性的水风的求助进行了留言
6秒前
美满的凝丝完成签到,获得积分10
6秒前
朽木发布了新的文献求助10
7秒前
Hosea完成签到 ,获得积分10
8秒前
小小完成签到 ,获得积分20
9秒前
Neo完成签到,获得积分10
9秒前
奋斗的忆南完成签到,获得积分10
10秒前
11秒前
Likz完成签到,获得积分10
12秒前
虚心天思完成签到,获得积分10
12秒前
领导范儿应助科研通管家采纳,获得10
13秒前
田様应助科研通管家采纳,获得10
13秒前
DannyKao应助科研通管家采纳,获得10
13秒前
大模型应助科研通管家采纳,获得10
13秒前
打打应助科研通管家采纳,获得10
13秒前
乐乐应助科研通管家采纳,获得10
13秒前
13秒前
zxj完成签到 ,获得积分10
15秒前
15秒前
小马甲应助积极白梦采纳,获得10
15秒前
15秒前
刘海鸥发布了新的文献求助20
15秒前
YOUNG-M发布了新的文献求助10
16秒前
橙汁摇一摇完成签到 ,获得积分10
18秒前
18秒前
23秒前
23秒前
雨洋发布了新的文献求助10
23秒前
酬勤完成签到,获得积分10
26秒前
小太阳发布了新的文献求助10
27秒前
Hello应助Tony Lee采纳,获得10
27秒前
雨山发布了新的文献求助10
28秒前
高分求助中
Teaching Social and Emotional Learning in Physical Education 900
Plesiosaur extinction cycles; events that mark the beginning, middle and end of the Cretaceous 800
Recherches Ethnographiques sue les Yao dans la Chine du Sud 500
Two-sample Mendelian randomization analysis reveals causal relationships between blood lipids and venous thromboembolism 500
Chinese-English Translation Lexicon Version 3.0 500
Wisdom, Gods and Literature Studies in Assyriology in Honour of W. G. Lambert 400
薩提亞模式團體方案對青年情侶輔導效果之研究 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2391823
求助须知:如何正确求助?哪些是违规求助? 2096649
关于积分的说明 5281811
捐赠科研通 1824208
什么是DOI,文献DOI怎么找? 909793
版权声明 559864
科研通“疑难数据库(出版商)”最低求助积分说明 486146